Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aptinyx Inc (APTX)

Aptinyx Inc (APTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptinyx Inc 909 DAVIS STREET SUITE 600 EVANSTON IL 60201 USA

www.aptinyx.com P: 847-871-0377

Description:

Aptinyx Inc. is a bio-pharmaceutical company. It focuses on discovery, development, and commercialization of novel, proprietary and synthetic small molecules for the treatment of brain and nervous system disorders. The company's product pipeline consists of NYX-2925, NYX-783 and NYX-458 which are in clinical stage. Aptinyx Inc. is based in IL, United States.

Key Statistics

Overview:

Market Capitalization, $K 6,501
Enterprise Value, $K -24,969
Shares Outstanding, K 67,720
Annual Sales, $ 0 K
Annual Net Income, $ -64,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,070 K
EBIT, $ -63,520 K
EBITDA, $ -63,400 K
60-Month Beta 1.21
% of Insider Shareholders 10.97%
% of Institutional Shareholders 0.00%
Float, K 60,291
% Float 89.03%
Short Volume Ratio 0.40

Growth:

1-Year Return -68.01%
3-Year Return -97.23%
5-Year Return -99.50%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 05/18/23
Next Earnings Date 01/02/24
Earnings Per Share ttm -0.98
EPS Growth vs. Prev Qtr -72.22%
EPS Growth vs. Prev Year -6.90%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

APTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 1.37
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.36
Book Value/Share 0.27
Interest Coverage -20.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar